Altamira Therapeutics Ltd. Transaction Price Allocated To Remaining Performance Obligations
Altamira Therapeutics Ltd. (CYTOF) had Transaction Price Allocated To Remaining Performance Obligations of $664.62 thousand as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations · last filed 2025-08-29
- 2025-06-30: Transaction Price Allocated To Remaining Performance Obligations $664.62K.
- 2024-12-31: Transaction Price Allocated To Remaining Performance Obligations $664.62K.
- 2023-12-31: Transaction Price Allocated To Remaining Performance Obligations $718.77K.
| Period end | Transaction Price Allocated To Remaining Performance Obligations |
|---|---|
| 2025-06-30 | $664.62K 6-K · filed 2025-08-29 |
| 2024-12-31 | $664.62K 20-F · filed 2025-04-30 |
| 2023-12-31 | $718.77K 6-K · filed 2025-08-29 |